As a fully integrated CMO, SEQENS is uniquely positioned to supply an entire suite of development, analytical and cGMP manufacturing services for licensed U.S. Drug Enforcement Administration (DEA) controlled substances.

Within our US and EU facilities, we produce bulk active pharmaceutical ingredients, New Chemical Entities (NCEs) for clinical supply, and other custom manufactured controlled substances for the life science industry.